Unity Biotechnology, Inc. Quarterly Revenue from Contract with Customer, Excluding Assessed Tax in USD from Q2 2021 to Q2 2023

Taxonomy & unit
us-gaap: USD
Description
Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.
Summary
Unity Biotechnology, Inc. annual/quarterly Revenue from Contract with Customer, Excluding Assessed Tax history and growth rate from Q2 2021 to Q2 2023.
  • Unity Biotechnology, Inc. Revenue from Contract with Customer, Excluding Assessed Tax for the quarter ending June 30, 2023 was $0.000, a 100% decline year-over-year.
  • Unity Biotechnology, Inc. annual Revenue from Contract with Customer, Excluding Assessed Tax for 2023 was $0.000, a 100% decline from 2022.
  • Unity Biotechnology, Inc. annual Revenue from Contract with Customer, Excluding Assessed Tax for 2022 was $236K, a 95.1% decline from 2021.
  • Unity Biotechnology, Inc. annual Revenue from Contract with Customer, Excluding Assessed Tax for 2021 was $4.78M.
Revenue from Contract with Customer, Excluding Assessed Tax, Quarterly (USD)
Revenue from Contract with Customer, Excluding Assessed Tax, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2023 $0 -$236K -100% Apr 1, 2023 Jun 30, 2023 10-K 2024-04-15
Q3 2022 $0 $0 Jul 1, 2022 Sep 30, 2022 10-K 2024-04-15
Q2 2022 $236K +$236K Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q3 2021 $0 Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 $0 Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.